
Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
Massimo Breccia, MD, is an associate professor and head of the Day Hospital Unit and Myeloid Disorders Unit Sapienza University of Rome in Rome, Italy.

Published: September 18th 2024 | Updated: